glp-1 birth defects receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders. https://ja.ma/3XPqgQT GLP-1 use during early pregnancy

DSIP is a very fancy band-aid for sleep issues

The clinical determination of which is more appropriate for you belongs to your assigned provider, not the marketing copy of either medication

Key Takeaways Tirzepatide and semaglutide are both once-weekly injectable medications for diabetes and weight management, but tirzepatide targets both GLP-1 and GIP receptors while semaglutide targets only GLP-1

Early investigations indicated that incubating dermal fibroblasts with nanomolar concentrations of GHK-Cu may have increased the synthesis of collagen, elastin, glycosaminoglycans (GAGs), and small proteoglycans such as decorin

Inclusion and exclusion criteria We included potentially relevant studies if they met the following inclusion criteria: (a) original randomised clinical trials with either parallel or cross-over design

BPC-157 stimulates fibroblasts, the cells responsible for producing collagen, while also influencing how new collagen fibers align